|
YWHAE expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.43750000020293E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.297400E-03 |
| Normal-vs-Stage2 |
3.456600E-03 |
| Normal-vs-Stage3 |
2.10579997883542E-09 |
| Normal-vs-Stage4 |
2.46190000052771E-07 |
| Stage1-vs-Stage2 |
2.115000E-01 |
| Stage1-vs-Stage3 |
4.44729999999893E-05 |
| Stage1-vs-Stage4 |
9.765800E-04 |
| Stage2-vs-Stage3 |
1.211560E-01 |
| Stage2-vs-Stage4 |
2.102600E-01 |
| Stage3-vs-Stage4 |
8.529000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.41849999974109E-07 |
| Normal-vs-AfricanAmerican |
9.73589999999636E-05 |
| Normal-vs-Asian |
7.413600E-01 |
| Caucasian-vs-AfricanAmerican |
4.298600E-01 |
| Caucasian-vs-Asian |
3.062400E-01 |
| AfricanAmerican-vs-Asian |
2.532800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08740000337448E-08 |
| Normal-vs-Female |
3.355700E-03 |
| Male-vs-Female |
1.824730E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.960000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.04149999999403E-05 |
| Normal-vs-Age(61-80Yrs) |
4.3525000004152E-07 |
| Normal-vs-Age(81-100Yrs) |
8.879900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.983400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.221600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.661630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.872600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.858240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.306000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.786800E-01 |
| Normal-vs-Grade 2 |
7.096000E-03 |
| Normal-vs-Grade 3 |
1.76809999974381E-08 |
| Normal-vs-Grade 4 |
6.85280054923965E-10 |
| Grade 1-vs-Grade 2 |
1.135170E-01 |
| Grade 1-vs-Grade 3 |
3.883800E-03 |
| Grade 1-vs-Grade 4 |
3.583400E-04 |
| Grade 2-vs-Grade 3 |
2.355300E-04 |
| Grade 2-vs-Grade 4 |
4.40949999958029E-07 |
| Grade 3-vs-Grade 4 |
1.844290E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.819800E-01 |
| Normal-vs-ccB subtype |
2.70690136972007E-11 |
| ccA subtype-vs-ccB subtype |
7.7715611723761E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.41729999999052E-05 |
| Normal-vs-N1 |
7.025900E-02 |
| N0-vs-N1 |
7.817200E-01 |
|
|
